# Icatibant

NDC: 46708-654
Generic name: Icatibant
Labeler / Manufacturer: Alembic Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20240614

FDA application: ANDA213773

## Active ingredients

- ICATIBANT ACETATE: 30 mg/3mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46708-654"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46708-654
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c149392-d281-4311-880f-3be2b4752f40